April 6 (Reuters) - Luminex Corp  LMNX.O :
    * LUMINEX RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR
ARIES®
SARS-COV-2 ASSAY TO DETECT VIRUS RESPONSIBLE FOR COVID-19
DISEASE
    * LUMINEX CORP - NXTAG COV EXTENDED PANEL AND ARIES
SARS-COV-2
ASSAY HAVE EACH BEEN FUNDED WITH $642,450 OF FEDERAL FUNDS
    * LUMINEX - FINANCED REMAINING $1.1 MILLION OF NXTAG COV
EXTENDED
PANEL AND ARIES SARS-COV-2 ASSAY

Source text for Eikon:  ID:nPn7zQ6fXa 
Further company coverage:  LMNX.O 

 (Reuters.Briefs@thomsonreuters.com)